Epigenomics News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

23.04.19	DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
15.04.19	DGAP-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Quartalsberichten und Quartals-/Zwischenmitteilungen (EQS Group)
15.04.19	DGAP-AFR: Epigenomics AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements (EQS Group)
02.04.19	DGAP-DD: Epigenomics AG english (EQS Group)
02.04.19	DGAP-DD: Epigenomics AG deutsch (EQS Group)
29.03.19	DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
29.03.19	DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
28.03.19	Epigenomics (ECX-DE): 2018 results highlight strong underlying growth momentum (EQS Group)
27.03.19	DGAP-News: Epigenomics AG Reports Results for Financial Year 2018 (EQS Group)
27.03.19	DGAP-News: Epigenomics AG veröffentlicht Finanzergebnisse für das Geschäftsjahr 2018 (EQS Group)
19.03.19	DGAP-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäss § 114, 115, 117 WpHG (EQS Group)
19.03.19	DGAP-AFR: Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] (EQS Group)
18.03.19	DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
15.03.19	DGAP-News: Epigenomics AG: U.S. Representatives Payne, Marchant, and Sewell Introduce Bi-Partisan Colorectal Cancer Detection Bill (EQS Group)
06.03.19	DGAP-Adhoc: Epigenomics AG terminates collaboration with Chinese licensing partner and announces anticipated revenue growth in 2019 outlook (EQS Group)
06.03.19	DGAP-Adhoc: Epigenomics AG beendet Zusammenarbeit mit chinesischem Lizenzpartner und veröffentlicht erwartete Umsatzsteigerung für 2019 (EQS Group)
06.03.19	DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
27.02.19	DGAP-PVR: Epigenomics AG: Correction of a release from 31/10/2018 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
27.02.19	DGAP-PVR: Epigenomics AG: Korrektur einer Veröffentlichung vom 31.10.2018 gemäss § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung (EQS Group)
18.02.19	DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
05.02.19	DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
11.01.19	DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
11.01.19	DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
07.01.19	DGAP-News: Epigenomics AG Announces Positive Results from Microsimulation Model (EQS Group)
07.01.19	DGAP-News: Epigenomics AG gibt positive Ergebnisse eines Mikrosimulationsmodells bekannt (EQS Group)
02.01.19	DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
02.01.19	DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
20.12.18	DGAP-News: Epigenomics AG Announces Initiation of a Prospective Clinical Study for Liver Cancer Detection (EQS Group)
20.12.18	DGAP-News: Epigenomics AG gibt den Beginn einer prospektiven klinischen Studie zur Erkennung von Leberkrebs bekannt (EQS Group)
20.12.18	DGAP-PVR: Epigenomics AG: Veröffentlichung gemäss § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung (EQS Group)
19.12.18	DGAP-News: Centers for Medicare & Medicaid Services veröffentlichen offiziellen Gebührenkatalog für klinische Laborleistungen 2019 inklusive Epi proColon(R) (EQS Group)
19.12.18	DGAP-News: Centers for Medicare & Medicaid Services issue official 2019 Clinical Lab Fee Schedule including Epi proColon(R) (EQS Group)
19.12.18	DGAP-PVR: Epigenomics AG: Veröffentlichung gemäss § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung (EQS Group)
19.12.18	DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
14.12.18	DGAP-DD: Epigenomics AG english (EQS Group)
14.12.18	DGAP-DD: Epigenomics AG deutsch (EQS Group)
14.12.18	DGAP-DD: Epigenomics AG deutsch (EQS Group)
14.12.18	DGAP-DD: Epigenomics AG english (EQS Group)
27.11.18	DGAP-PVR: Epigenomics AG: Correction of a release from 27/11/2018 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
27.11.18	DGAP-PVR: Epigenomics AG: Korrektur einer Veröffentlichung vom 27.11.2018 gemäss § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung (EQS Group)
27.11.18	DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
27.11.18	DGAP-PVR: Epigenomics AG: Veröffentlichung gemäss § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung (EQS Group)
22.11.18	DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
22.11.18	DGAP-PVR: Epigenomics AG: Veröffentlichung gemäss § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung (EQS Group)
08.11.18	Epigenomics (ECX-DE): Q3 -Milestone completion triggers more commercial momentum (EQS Group)
07.11.18	DGAP-PVR: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
07.11.18	DGAP-PVR: Veröffentlichung gemäss § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung (EQS Group)
07.11.18	DGAP-News: Epigenomics AG: Epigenomics AG Announces 2018 Third Quarter and Nine Months Financial Results (EQS Group)
05.11.18	DGAP-PVR: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
05.11.18	DGAP-PVR: Veröffentlichung gemäss § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung (EQS Group)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	76.62	0.39 %	K V
Part Grp Hldg	1’271.50	0.36 %	K V
Holcim	89.08	0.25 %	K V
Logitech Intl	74.82	-0.05 %	K V
Lonza Grp	540.60	-0.15 %	K V
UBS Group	27.82	-1.24 %	K V
Sika	223.10	-1.37 %	K V
Nestle	74.10	-1.49 %	K V
Swiss Re	129.60	-1.78 %	K V
Givaudan	3’961.00	-2.46 %	K V